Author pages are created from data sourced from our academic publisher partnerships and public sources.
Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo.
Abstract Patients' perspectives concerning the effects of disease and therapy on their lives have become increasingly important for the assessment of medications in clinical trials. The Minnesota… Expand
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Neuroendocrine activation is known to occur in patients with congestive heart failure, but there is uncertainty as to whether this occurs before or after the presence of overt symptoms. In the… Expand
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.
BACKGROUND We conducted a multicenter, placebo-controlled trial designed to establish the efficacy and safety of carvedilol, a "third-generation" beta -blocking agent with vasodilator properties, in… Expand
Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
- R. Cody, S. Atlas, +7 authors M. J. Camargo
- The Journal of clinical investigation
- 1 November 1986
We investigated atrial natriuretic factor (ANF) in humans, measuring plasma immunoreactive (ir) ANF (in femtomoles per milliliter), and renal, hormonal, and hemodynamic responses to ANF infusion, in… Expand
Endothelium‐Dependent Vasodilation Is Attenuated in Patients With Heart Failure
BackgroundEndothelial cells produce a number of substances, collectively termed endothelium derived relaxing factor (EDRF), that promote local relaxation of vascular smooth muscle. Although studies… Expand
Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure.
BACKGROUND Patients with heart failure have reduced peripheral blood flow at rest, during exercise, and in response to endothelium-dependent vasodilators. Nitric oxide formed from L-arginine… Expand
Vagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF Trial.
- M. Gold, D. V. van Veldhuisen, +10 authors D. Mann
- Journal of the American College of Cardiology
- 12 July 2016
BACKGROUND Heart failure (HF) is increasing in prevalence and is a major cause of morbidity and mortality despite advances in medical and device therapy. Autonomic imbalance, with excess sympathetic… Expand
Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection.
- K. McDonald, T. Rector, E. Braulin, S. Kubo, M. T. Olivari
- The American journal of cardiology
- 1 August 1989
Coronary artery disease (CAD) is now the major limitation to long-term survival after cardiac transplantation. Its etiology remains unclear. The possible role of viral infection in the genesis of CAD… Expand
Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death.
Treatments for heart failure, such as flosequinan, may have opposite effects on survival and quality of life. The Living With Heart Failure questionnaire was used to examine patients' willingness to… Expand
Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics.
- S. Kubo, B. A. Walter, D. H. John, M. Clark, R. Cody
- Archives of internal medicine
- 1 July 1987
To characterize the incidence and severity of liver function abnormalities in patients with congestive heart failure, we analyzed systemic hemodynamics and biochemical profiles in 133 patients with… Expand